Ozempic is also a GLP-1 receptor agonist, which is FDA-approved for managing type 2 diabetes, reducing the risk of cardiovascular diseases, and preventing kidney failure in patients with chronic kidney disease and type 2 diabetes
Gastrointestinal symptoms frequently change character during switching
Commercial GLP-1s (brand names Ozempic, Wegovy, Mounjaro and Zepbound) are regulated by the Food and Drug Administration (FDA) for safety, quality and effectiveness
Benefit 6: Reduces Chronic Inflammation Chronic inflammation underlies many illnesses, including autoimmune diseases, vector-borne illnesses like Lyme disease and co-infections, IBD, and lung conditions like asthma, COPD, cystic fibrosis